SCHEMBL20006407

SCHEMBL20006407

CC(C)(C)C(=O)NCCCCCC(=O)Cl

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
TSHR P16473 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 2/20 0.45
EPHX1 P07099 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
DRD4 P21917 6/20 0.42
DRD2 P14416 5/20 0.42
ADRA1A P35348 1/20 0.41
KDM4E B2RXH2 2/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
HIF1A Q16665 1/20 0.40
PRMT1 Q99873 1/20 0.39
CACNA1H O95180 1/20 0.38
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10633351 0.85 MEN1 (0.58) ALDH1A1MEN1KMT2APOLBEPHX1
SCHEMBL18622113 0.83 POLB (0.57) ALDH1A1MEN1KMT2APOLBEPHX1
SCHEMBL25868825 0.82 MEN1 (0.47) ALDH1A1MEN1KMT2APOLBEPHX1
SCHEMBL15981919 0.82 ADRA1A (0.62) TSHRMEN1KMT2APOLBADRA1A
SCHEMBL10172327 0.82 MEN1 (0.47) ALDH1A1MEN1KMT2APOLBEPHX1
SCHEMBL518264 0.81 MEN1 (0.73) ALDH1A1TSHRMEN1KMT2APOLB
SCHEMBL7800974 0.81 MEN1 (0.45) ALDH1A1MEN1KMT2APOLBEPHX1
SCHEMBL5145403 0.81 MEN1 (0.45) ALDH1A1MEN1KMT2APOLBEPHX1
SCHEMBL31457188 0.80 ADRA1A (0.59) ALDH1A1TSHRPOLBSMN1; SMN2ADRA1A
SCHEMBL14818994 0.79 POLB (0.50) ALDH1A1MEN1KMT2APOLBEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10201632-B2 Polymer particles TERUMO CORPORATION (JP) 2019-02-12 US disclosed
US-20180085497-A1 POLYMER PARTICLES TERUMO CORPORATION (JP) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10201632-B2 Polymer particles FGB, PLG, PLAT ALDH1A1 3057/4885TSHR 2814/4885MEN1 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.